RHUMBLINE ADVISERS

Position in HLN — Haleon plc

CIK 1115418 BOSTON, MA

Position in HLN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$475,988

-$435,772 QoQ

Shares Held

51,017

-44.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#198

of 639 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. HLN ranks #34 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,437,213	$103,278,126
2	UTHR	UNITED THERAPEUTICS Corp	120,078	$65,061,862
3	NBIX	Neurocrine Biosciences Inc	312,832	$52,724,705
4	VTRS	Viatris Inc	2,872,464	$45,614,728
5	ELAN	Elanco Animal Health Inc	1,264,159	$31,110,952
6	HIMS	Hims & Hers Health, Inc.	633,778	$21,973,083
7	LNTH	Lantheus Holdings, Inc.	197,060	$21,861,836
8	ALKS	Alkermes plc.	387,999	$20,331,147

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$475,988	51,017	-44.0%	Shares	Sole	2026-08-12
2026-03-31	$911,760	91,085	+5.6%	Shares	Sole	2026-05-12
2025-12-31	$871,744	86,226	+56.5%	Shares	Sole	2026-02-13
2025-09-30	$494,076	55,081	-2.7%	Shares	Sole	2025-11-06
2025-06-30	$587,201	56,625	-1.6%	Shares	Sole	2025-08-12
2025-03-31	$591,952	57,527	+6.7%	Shares	Sole	2025-05-29
2024-12-31	$514,225	53,902	+1.7%	Shares	Sole	2025-05-29
2024-09-30	$560,697	52,996	+8.2%	Shares	Sole	2024-11-12
2024-06-30	$404,459	48,966	+20.0%	Shares	Sole	2024-08-01
2024-03-31	$346,442	40,806	+35.2%	Shares	Sole	2024-05-09
2023-12-31	$248,488	30,193	+4.5%	Shares	Sole	2024-02-08
2023-09-30	$240,612	28,885	+35.8%	Shares	Sole	2023-11-09
2023-06-30	$178,284	21,275	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.